หน้าผลลัพธ์ 2 สำหรับ หมวดธุรกิจ: การดูแลสุขภาพ อุตสาหกรรม: ผู้ผลิตยา - ทั่วไป ตลาดหุ้น - โควตและราคา
รายชื่อหุ้นและตราสารทุนทั้งหมดพร้อมราคา มูลค่าตามราคาตลาด PE และ EPS
ประเทศทั้งหมด
- {{country.name}}
- ประเทศทั้งหมด
- สหรัฐอเมริกา (49)
- อาร์เจนตินา (13)
- ออสเตรเลีย (1)
- ออสเตรีย (13)
- บราซิล (14)
- แคนาดา (2)
- ชิลี (4)
- จีน (12)
- ฟินแลนด์ (2)
- ฝรั่งเศส (3)
- เยอรมนี (58)
- ฮ่องกง (2)
- ฮังการี (1)
- อินเดีย (20)
- อิตาลี (5)
- ญี่ปุ่น (9)
- เม็กซิโก (14)
- สิงคโปร์ (1)
- เกาหลีใต้ (3)
- สเปน (1)
- สวีเดน (3)
- สวิตเซอร์แลนด์ (6)
- ไต้หวัน (1)
- ตุรกี (1)
- สหราชอาณาจักร (20)
กระดานเทรดทั้งหมด
- {{item.name}}
- กระดานเทรดทั้งหมด
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (2)
- IOB (17)
- Istanbul (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (8)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (5)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (6)
- Shenzhen (6)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
การดูแลสุขภาพ (265)
- {{item.name}}
- หมวดธุรกิจทั้งหมด
- การดูแลสุขภาพ (265)
ผู้ผลิตยา - ทั่วไป (265)
- {{item.name}}
- อุตสาหกรรมทั้งหมด
- เทคโนโลยีชีวภาพ (2608)
- ผู้ผลิตยา - ทั่วไป (265)
- ผู้ผลิตยา - เฉพาะทางและทั่วไป (1632)
- แผนการดูแลสุขภาพ (57)
- สิ่งอำนวยความสะดวกการดูแลทางการแพทย์ (554)
- ผู้ค้าปลีกเภสัชภัณฑ์ (155)
- บริการข้อมูลด้านสุขภาพ (419)
- อุปกรณ์ทางการแพทย์ (916)
- เครื่องมือและอุปกรณ์ทางการแพทย์ (501)
- การวินิจฉัยและการวิจัย (429)
- การจำหน่ายทางการแพทย์ (138)
| ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS |
|---|
| ชื่อ ชื่อ | ราคา ราคา |
% 24 ชม. กราฟ 7 วัน % 24 ชม. และ 7 วัน |
มูลค่าตลาด มูลค่าตามราคาตลาด | วอลุ่ม วอลุ่ม | ต่ำสุดในช่วง 24 ชม. | สูงสุดในช่วง 24 ชม. | มูลค่าตามราคาตลาด | อัตราส่วน P/E | EPS | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJB34.SA | $56.25 11.4 USD |
-0.34
|
$2.03T 411.78B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.03T 411.78B USD | 17.30 | $3.25 0.66 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV.MX | $3,547.33 210.05 USD |
0
|
$6.27T 371.02B USD | $1 0.06 USD | $3,547.33 210.05 USD | $3,547.33 210.05 USD | $6.27T 371.02B USD | 81.30 | $43.63 2.58 USD | |
| AbbVie Inc. ABBV34.SA | $62.81 12.73 USD |
-3.67
|
$1.81T 366.77B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.81T 366.77B USD | 79.50 | $0.79 0.16 USD | |
| Novartis AG NVS.BA | $38,700 45.74 USD |
0
|
$300.51T 355.21B USD | $0 0 USD | $0 0 USD | $0 0 USD | $300.51T 355.21B USD | 2.46 | $15.72K 18.58 USD | |
| Johnson & Johnson JNJ.F | $132.38 144.71 USD |
+0.23
|
$318.9B 348.6B USD | $234 255.79 USD | $131.14 143.35 USD | $132.38 144.71 USD | $318.9B 348.6B USD | 17.32 | $7.64 8.35 USD | |
| Johnson & Johnson JNJ.DE | $132.48 144.82 USD |
-0.03
|
$318.9B 348.6B USD | $1.12K 1.23K USD | $131.78 144.05 USD | $132.7 145.06 USD | $318.9B 348.6B USD | 17.34 | $7.64 8.35 USD | |
| Johnson & Johnson JNJ.VI | $132.46 144.8 USD |
-0.03
|
$318.9B 348.6B USD | $111 121.34 USD | $131.96 144.25 USD | $132.56 144.91 USD | $318.9B 348.6B USD | 17.38 | $7.62 8.33 USD | |
| AstraZeneca PLC AZN.BA | $43,000 50.83 USD |
-0.69
|
$269.68T 318.77B USD | $18 0.02 USD | $43,000 50.83 USD | $43,025 50.86 USD | $269.68T 318.77B USD | 7.02 | $6.12K 7.23 USD | |
| AbbVie Inc. 4AB.DE | $161 175.99 USD |
-0.12
|
$284.39B 310.88B USD | $288 314.82 USD | $157.4 172.06 USD | $161 175.99 USD | $284.39B 310.88B USD | 81.31 | $1.98 2.16 USD | |
| AbbVie Inc. ABBV.VI | $160 174.9 USD |
-0.62
|
$284.05B 310.5B USD | $0 0 USD | $160 174.9 USD | $160.8 175.78 USD | $284.05B 310.5B USD | 80.80 | $1.98 2.16 USD | |
| AbbVie Inc. 4AB.F | $159 173.81 USD |
-1.12
|
$284.05B 310.5B USD | $338 369.48 USD | $159 173.81 USD | $160.6 175.56 USD | $284.05B 310.5B USD | 79.89 | $1.99 2.18 USD | |
| Merck & Co., Inc. MRK.BA | $20,575 24.32 USD |
+2.49
|
$255.23T 301.69B USD | $636 0.75 USD | $20,100 23.76 USD | $20,600 24.35 USD | $255.23T 301.69B USD | 0.24 | $84.73K 100.15 USD | |
| Roche Holding AG ROGN.MX | $6,067 359.24 USD |
0
|
$4.9T 290.03B USD | $0 0 USD | $6,067 359.24 USD | $6,067 359.24 USD | $4.9T 290.03B USD | 25.06 | $242.07 14.33 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.55T 269.51B USD | $0 0 USD | $2,092.19 123.88 USD | $2,092.19 123.88 USD | $4.55T 269.51B USD | 17.57 | $119.05 7.05 USD | |
| Novartis AG N1VS34.SA | $66.83 13.55 USD |
0
|
$1.32T 267.72B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.32T 267.72B USD | 19.37 | $3.45 0.7 USD | |
| Roche Holding AG RHHBF | $333.36 — |
0
|
$262.6B — | $1 — | $340 — | $340 — | $262.6B — | 25.58 | $13.03 — | |
| Roche Holding AG RHO6.F | $34.35 37.55 USD |
+0.13
|
$223.09B 243.87B USD | $1.35K 1.47K USD | $34.02 37.19 USD | $34.8 38.04 USD | $223.09B 243.87B USD | 24.89 | $1.38 1.51 USD | |
| AstraZeneca PLC AZNN.MX | $1,310 77.57 USD |
0
|
$4.08T 241.85B USD | $1 0.06 USD | $1,310 77.57 USD | $1,310 77.57 USD | $4.08T 241.85B USD | 28.25 | $46.37 2.75 USD | |
| AstraZeneca PLC A1ZN34.SA | $64.09 12.99 USD |
+1.44
|
$1.19T 241.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.19T 241.65B USD | 28.61 | $2.24 0.45 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Amgen Inc. AMGN.BA | $12,450 14.72 USD |
+0.4
|
$197.1T 232.98B USD | $1.16K 1.37 USD | $12,400 14.66 USD | $13,150 15.54 USD | $197.1T 232.98B USD | 0.18 | $67.55K 79.85 USD | |
| Novartis AG NOTA.F | $101 110.41 USD |
-1.46
|
$207.3B 226.61B USD | $1 1.09 USD | $101 110.41 USD | $101 110.41 USD | $207.3B 226.61B USD | 18.63 | $5.42 5.92 USD | |
| Merck & Co., Inc. MRK.MX | $1,510 89.41 USD |
0
|
$3.79T 224.51B USD | $14 0.83 USD | $1,510 89.41 USD | $1,510 89.41 USD | $3.79T 224.51B USD | 11.76 | $128.35 7.6 USD | |
| Merck & Co., Inc. MRCK34.SA | $53.71 10.89 USD |
-1.45
|
$1.1T 222.93B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.1T 222.93B USD | 11.52 | $4.66 0.94 USD | |
| AstraZeneca PLC AZNCF | $140.69 — |
-2.22
|
$218.1B — | $300 — | $138.57 — | $139 — | $218.1B — | 28.30 | $4.97 — | |
| Merck & Co., Inc. MRK.SN | $82 — |
+3.68
|
$210.69B — | $0 — | $82 — | $82 — | $210.69B — | 11.91 | $6.88 — | |
| Pfizer Inc. PFE.BA | $7,800 9.22 USD |
-0.89
|
$175.68T 207.66B USD | $7.45K 8.8 USD | $7,650 9.04 USD | $8,120 9.6 USD | $175.68T 207.66B USD | 2.29 | $3.4K 4.02 USD | |
| AstraZeneca PLC ZEG.F | $120.55 131.78 USD |
-0.21
|
$186.88B 204.29B USD | $703 768.47 USD | $117.95 128.94 USD | $120.55 131.78 USD | $186.88B 204.29B USD | 28.56 | $4.22 4.61 USD | |
| AstraZeneca PLC ZEGA.F | $59.5 65.04 USD |
-0.83
|
$186.03B 203.36B USD | $300 327.94 USD | $59.5 65.04 USD | $59.5 65.04 USD | $186.03B 203.36B USD | 28.19 | $2.11 2.31 USD | |
| Gilead Sciences, Inc. GILD.BA | $34,425 40.69 USD |
+0.36
|
$171.19T 202.36B USD | $67 0.08 USD | $33,075 39.1 USD | $34,425 40.69 USD | $171.19T 202.36B USD | 5.87 | $5.86K 6.93 USD | |
| Merck & Co., Inc. 6MK.DE | $70 76.52 USD |
+1.16
|
$175.77B 192.14B USD | $1.51K 1.66K USD | $68.4 74.77 USD | $70 76.52 USD | $175.77B 192.14B USD | 11.96 | $5.85 6.39 USD | |
| Merck & Co., Inc. MRK.VI | $69.1 75.54 USD |
0
|
$173.51B 189.67B USD | $200 218.63 USD | $68.5 74.88 USD | $69.1 75.54 USD | $173.51B 189.67B USD | 11.85 | $5.83 6.37 USD | |
| Merck & Co., Inc. 6MK.F | $68.6 74.99 USD |
-0.72
|
$172.65B 188.72B USD | $3.44K 3.76K USD | $68.6 74.99 USD | $68.8 75.21 USD | $172.65B 188.72B USD | 11.74 | $5.84 6.38 USD | |
| Amgen Inc. AMGN34.SA | $58.32 11.82 USD |
0
|
$878.05B 177.97B USD | $0 0 USD | $0 0 USD | $0 0 USD | $878.05B 177.97B USD | 27.50 | $2.12 0.43 USD | |
| Amgen Inc. AMGN.MX | $5,568.7 329.74 USD |
0
|
$2.99T 177.3B USD | $0 0 USD | $5,568.7 329.74 USD | $5,568.7 329.74 USD | $2.99T 177.3B USD | 27.24 | $204.37 12.1 USD | |
| Pfizer Inc. PFIZ34.SA | $35.13 7.12 USD |
+2.12
|
$798.91B 161.93B USD | $0 0 USD | $0 0 USD | $0 0 USD | $798.91B 161.93B USD | 18.78 | $1.87 0.38 USD | |
| Pfizer Inc. PFE.MX | $479.99 28.42 USD |
+1.4
|
$2.73T 161.59B USD | $52 3.08 USD | $470 27.83 USD | $479.99 28.42 USD | $2.73T 161.59B USD | 18.65 | $25.73 1.52 USD | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1 — | $0 — | $0 — | $157.63B — | 19.38 | $14.84 — | |
| Gilead Sciences, Inc. GILD.MX | $2,098.47 124.26 USD |
0
|
$2.61T 154.56B USD | $0 0 USD | $2,098.47 124.26 USD | $2,098.47 124.26 USD | $2.61T 154.56B USD | 23.63 | $88.77 5.26 USD | |
| Gilead Sciences, Inc. GILD34.SA | $300 60.81 USD |
+0.33
|
$752.36B 152.49B USD | $0 0 USD | $0 0 USD | $0 0 USD | $752.36B 152.49B USD | 23.31 | $12.87 2.61 USD | |
| Amgen Inc. AMG.F | $254.15 277.82 USD |
+1.09
|
$136.66B 149.39B USD | $31 33.89 USD | $252.1 275.58 USD | $254.15 277.82 USD | $136.66B 149.39B USD | 27.24 | $9.33 10.2 USD | |
| Amgen Inc. AMG.DE | $252 275.47 USD |
-0.28
|
$136.24B 148.93B USD | $67 73.24 USD | $252 275.47 USD | $254 277.66 USD | $136.24B 148.93B USD | 27.03 | $9.32 10.19 USD | |
| Amgen Inc. AMGN.VI | $252.35 275.85 USD |
-0.18
|
$136.24B 148.93B USD | $30 32.79 USD | $252.35 275.85 USD | $253.55 277.16 USD | $136.24B 148.93B USD | 27.16 | $9.29 10.16 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.47 — |
+0.04
|
$139.06B — | $0 — | $110.47 — | $110.47 — | $139.06B — | 23.20 | $4.76 — | |
| Bristol-Myers Squibb Company BMY.BA | $19,325 22.84 USD |
-0.26
|
$117.29T 138.64B USD | $91 0.11 USD | $19,325 22.84 USD | $20,000 23.64 USD | $117.29T 138.64B USD | 5.85 | $3.3K 3.9 USD | |
| Pfizer Inc. PFE.SN | $23.8 — |
-8.67
|
$135.31B — | $0 — | $23.8 — | $23.8 — | $135.31B — | 17.24 | $1.38 — | |
| Pfizer Inc. PFE.VI | $21.56 23.57 USD |
-0.32
|
$122.59B 134B USD | $186 203.32 USD | $21.52 23.52 USD | $21.57 23.57 USD | $122.59B 134B USD | 18.42 | $1.17 1.28 USD | |
| Pfizer Inc. PFEB.F | $7 7.65 USD |
+0.72
|
$122.59B 134B USD | $40 43.73 USD | $7 7.65 USD | $7 7.65 USD | $122.59B 134B USD | 17.50 | $0.4 0.44 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Gilead Sciences, Inc. GILD.VI | $93.91 102.66 USD |
-0.95
|
$118.1B 129.1B USD | $0 0 USD | $93.91 102.66 USD | $94.66 103.48 USD | $118.1B 129.1B USD | 23.24 | $4.04 4.42 USD | |
| Gilead Sciences, Inc. GIS.DE | $94.44 103.24 USD |
-0.35
|
$118.1B 129.1B USD | $540 590.29 USD | $93.87 102.61 USD | $94.71 103.53 USD | $118.1B 129.1B USD | 23.37 | $4.04 4.42 USD | |
| Gilead Sciences, Inc. GIS.F | $94.88 103.72 USD |
+0.08
|
$118.1B 129.1B USD | $81 88.54 USD | $94.81 103.64 USD | $94.88 103.72 USD | $118.1B 129.1B USD | 23.48 | $4.04 4.42 USD | |
| GSK plc GSK.BA | $11,750 13.89 USD |
-0.84
|
$95.63T 113.04B USD | $46 0.05 USD | $11,400 13.48 USD | $11,800 13.95 USD | $95.63T 113.04B USD | 18.34 | $640.38 0.76 USD | |
| Sanofi SNW.F | $83.2 90.95 USD |
+0.85
|
$101.41B 110.85B USD | $887 969.61 USD | $82 89.64 USD | $83.2 90.95 USD | $101.41B 110.85B USD | 16.67 | $4.99 5.45 USD | |
| Sanofi SANO.VI | $82.81 90.52 USD |
+0.06
|
$101.41B 110.85B USD | $122 133.36 USD | $82.17 89.82 USD | $82.81 90.52 USD | $101.41B 110.85B USD | 16.59 | $4.99 5.45 USD | |
| Sanofi SNW2.F | $40.6 44.38 USD |
-0.98
|
$101.41B 110.85B USD | $100 109.31 USD | $40.6 44.38 USD | $40.6 44.38 USD | $101.41B 110.85B USD | 16.23 | $2.5 2.73 USD | |
| Bristol-Myers Squibb Company BMY.MX | $900.49 53.32 USD |
0
|
$1.83T 108.51B USD | $1 0.06 USD | $900.49 53.32 USD | $900.49 53.32 USD | $1.83T 108.51B USD | 18.01 | $49.98 2.96 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $252.01 51.08 USD |
-11.58
|
$516.8B 104.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $516.8B 104.75B USD | 17.35 | $14.52 2.94 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $791 46.84 USD |
0
|
$1.6T 94.72B USD | $0 0 USD | $791 46.84 USD | $791 46.84 USD | $1.6T 94.72B USD | 20.40 | $38.76 2.3 USD | |
| Bristol-Myers Squibb Company BRM.DE | $40.1 43.83 USD |
+0.35
|
$81.6B 89.2B USD | $5K 5.46K USD | $39.53 43.21 USD | $40.1 43.83 USD | $81.6B 89.2B USD | 17.58 | $2.28 2.49 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $39.76 43.46 USD |
-0.55
|
$81.12B 88.68B USD | $0 0 USD | $39.53 43.21 USD | $40.06 43.79 USD | $81.12B 88.68B USD | 17.51 | $2.27 2.48 USD | |
| Bristol-Myers Squibb Company BRM.F | $39.7 43.4 USD |
-1.74
|
$81.12B 88.68B USD | $400 437.25 USD | $39.7 43.4 USD | $40.1 43.83 USD | $81.12B 88.68B USD | 17.41 | $2.28 2.49 USD | |
| GSK plc G1SK34.SA | $41.78 8.47 USD |
-0.05
|
$422.46B 85.63B USD | $0 0 USD | $0 0 USD | $0 0 USD | $422.46B 85.63B USD | 18.56 | $2.25 0.46 USD | |
| Chugai Pharmaceutical CHGCF | $46.69 — |
-9.99
|
$81.02B — | $200 — | $52 — | $52 — | $81.02B — | 26.83 | $1.74 — | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $41.15 44.98 USD |
+0.51
|
$68.83B 75.25B USD | $1 1.09 USD | $41.15 44.98 USD | $41.43 45.29 USD | $68.83B 75.25B USD | 28.18 | $1.46 1.6 USD | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $19 20.77 USD |
+1.01
|
$35.39B 38.69B USD | $263 287.49 USD | $19 20.77 USD | $19 20.77 USD | $35.39B 38.69B USD | 20.65 | $0.92 1.01 USD | |
| Bayer Aktiengesellschaft BAYZF | $30.92 — |
-0.9
|
$30.38B — | $2.5K — | $31.1 — | $31.1 — | $30.38B — | 0 | -$3.92 — | |
| Bayer Aktiengesellschaft BAYER.BD | $10,572 29.24 USD |
0
|
$10.39T 28.73B USD | $120 0.33 USD | $10,450 28.9 USD | $10,572 29.24 USD | $10.39T 28.73B USD | 0 | -$1,329 -3.6 USD | |
| Biogen Inc. BIIB.BA | $12,900 15.25 USD |
+0.78
|
$23.98T 28.34B USD | $117 0.14 USD | $12,250 14.48 USD | $12,925 15.28 USD | $23.98T 28.34B USD | 1.03 | $12.46K 14.73 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $26.08 28.51 USD |
-0.15
|
$25.73B 28.13B USD | $432 472.23 USD | $25.91 28.32 USD | $26.08 28.51 USD | $25.73B 28.13B USD | 0 | -$3.32 -3.6 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6.35 6.94 USD |
-7.3
|
$25.73B 28.13B USD | $40 43.73 USD | $6.3 6.89 USD | $6.35 6.94 USD | $25.73B 28.13B USD | 0 | -$0.83 -0.9 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $39.4 43.07 USD |
-1.5
|
$21B 22.95B USD | $12 13.12 USD | $39.4 43.07 USD | $39.6 43.29 USD | $21B 22.95B USD | 10.34 | $3.81 4.16 USD | |
| Biogen Inc. BIIB34.SA | $124.32 25.2 USD |
0
|
$109.74B 22.24B USD | $0 0 USD | $0 0 USD | $0 0 USD | $109.74B 22.24B USD | 13.67 | $9.09 1.84 USD | |
| Biogen Inc. BIIB.MX | $2,534.61 150.08 USD |
0
|
$371.39B 21.99B USD | $0 0 USD | $2,534.61 150.08 USD | $2,534.61 150.08 USD | $371.39B 21.99B USD | 13.42 | $188.83 11.18 USD | |
| Biogen Inc. IDP.F | $112.3 122.76 USD |
-0.35
|
$16.54B 18.08B USD | $120 131.18 USD | $112.3 122.76 USD | $112.3 122.76 USD | $16.54B 18.08B USD | 13.05 | $8.6 9.4 USD | |
| Biogen Inc. BIIB.VI | $112.45 122.92 USD |
-0.44
|
$16.54B 18.08B USD | $0 0 USD | $112.35 122.81 USD | $112.55 123.03 USD | $16.54B 18.08B USD | 13.10 | $8.58 9.38 USD | |
| Biogen Inc. IDP.DE | $112.45 122.92 USD |
-0.27
|
$16.54B 18.08B USD | $2 2.19 USD | $111.7 122.1 USD | $112.45 122.92 USD | $16.54B 18.08B USD | 13.07 | $8.6 9.4 USD | |
| Astellas Pharma ALPMF | $9.61 — |
0
|
$17.35B — | $100 — | $10.1 — | $10.1 — | $17.35B — | 48.04 | $0.2 — | |
| Astellas Pharma Inc. YPH.F | $7.95 8.69 USD |
-0.25
|
$14.74B 16.11B USD | $100 109.31 USD | $7.95 8.69 USD | $8.05 8.8 USD | $14.74B 16.11B USD | 46.77 | $0.17 0.19 USD | |
| Astellas Pharma Inc. YPHA.F | $7.95 8.69 USD |
+0.63
|
$14.74B 16.11B USD | $26 28.42 USD | $7.95 8.69 USD | $7.95 8.69 USD | $14.74B 16.11B USD | 46.76 | $0.17 0.19 USD | |
| Cipla Limited CIPLA.BO | $1,514.6 18.32 USD |
+0.4
|
$1.22T 14.8B USD | $11.75K 142.18 USD | $1,500.35 18.15 USD | $1,520 18.39 USD | $1.22T 14.8B USD | 23.21 | $65.23 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $54.05 59.08 USD |
+0.84
|
$11.11B 12.15B USD | $0 0 USD | $53.35 58.32 USD | $54.05 59.08 USD | $11.11B 12.15B USD | 27.02 | $2 2.19 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $53.85 58.87 USD |
+0.75
|
$11.11B 12.15B USD | $30 32.79 USD | $53.2 58.15 USD | $53.85 58.87 USD | $11.11B 12.15B USD | 26.92 | $2 2.19 USD | |
| CSPC Pharmaceutical CHJTF | $1.05 — |
0
|
$11.99B — | $19.71K — | $1.05 — | $1.05 — | $11.99B — | 20.99 | $0.05 — | |
| CSPC Pharmaceutical CSPCY | $4.12 — |
+4.49
|
$11.86B — | $10K — | $4.12 — | $4.12 — | $11.86B — | 19.61 | $0.21 — | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.8699 0.95 USD |
-1
|
$10.07B 11.01B USD | $742 811.11 USD | $0.8699 0.95 USD | $0.8699 0.95 USD | $10.07B 11.01B USD | 21.71 | $0.04 0.04 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $3.38 3.69 USD |
+1.81
|
$10.07B 11.01B USD | $4.69K 5.12K USD | $3.38 3.69 USD | $3.38 3.69 USD | $10.07B 11.01B USD | 19.88 | $0.17 0.19 USD | |
| Orion Oyj ORINY | $37.18 — |
0
|
$10.45B — | $8 — | $37.99 — | $37.99 — | $10.45B — | 25.46 | $1.46 — | |
| Orion Oyj OFK0.F | $30.8 33.67 USD |
0
|
$8.88B 9.7B USD | $0 0 USD | $30.8 33.67 USD | $30.8 33.67 USD | $8.88B 9.7B USD | 24.83 | $1.24 1.36 USD | |
| Orion Oyj OFK.F | $62.75 68.59 USD |
+1.37
|
$8.88B 9.7B USD | $81 88.54 USD | $61.7 67.45 USD | $63.1 68.98 USD | $8.88B 9.7B USD | 25.30 | $2.48 2.71 USD | |
| Kyowa Kirin KYKOF | $14.95 — |
0
|
$9.09B — | $63 — | $16.75 — | $16.75 — | $9.09B — | 21.98 | $0.68 — | |
| Abbott India Limited ABBOTINDIA.NS | $34,760 420.54 USD |
-1.86
|
$738.87B 8.94B USD | $9.98K 120.72 USD | $34,660 419.33 USD | $35,675 431.61 USD | $738.87B 8.94B USD | 52.12 | $666.91 8.07 USD | |
| Abbott India Limited ABBOTINDIA.BO | $34,700 419.81 USD |
-2.21
|
$737.35B 8.92B USD | $399 4.83 USD | $34,684.8 419.63 USD | $35,606.45 430.78 USD | $737.35B 8.92B USD | 52.01 | $667.13 8.07 USD | |
| Kyowa Kirin Co., Ltd. KY4.F | $14.5 15.85 USD |
+0.69
|
$7.72B 8.44B USD | $30 32.79 USD | $14.5 15.85 USD | $14.6 15.96 USD | $7.72B 8.44B USD | 25.43 | $0.57 0.62 USD | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
| Grifols GIFLF | $11.45 — |
0
|
$7.59B — | $1.33K — | $10.95 — | $10.95 — | $7.59B — | 42.40 | $0.27 — | |
|
ไม่มีหุ้นที่ชื่นชอบ
คุณยังไม่มีหุ้นที่ชื่นชอบ กรุณาเพิ่มลงในรายการโปรดเพื่อดูที่นี่ |
||||||||||
- {{ link.label }} {{link}}